57 related articles for article (PubMed ID: 25335731)
1. Evaluation of inflammatory biomarkers as helping diagnostic tool in patients with breast cancer.
Baskic D; Popovic S; Bankovic D; Arsovic A; Vukovic V; Zelen I; Djurdjevic P
Cancer Biomark; 2014; 14(6):401-8. PubMed ID: 25335731
[TBL] [Abstract][Full Text] [Related]
2. Significance of vascular endothelial growth factor, interleukin-18 and nitric oxide in patients with breast cancer: correlation with carbohydrate antigen 15.3.
Metwally FM; El-mezayen HA; Ahmed HH
Med Oncol; 2011 Dec; 28 Suppl 1():S15-21. PubMed ID: 20725807
[TBL] [Abstract][Full Text] [Related]
3. Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.
Günel N; Coşkun U; Sancak B; Günel U; Hasdemir O; Bozkurt S
Cancer; 2002 Aug; 95(3):663-7. PubMed ID: 12209760
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of serum hepatocyte growth factor, B-cell lymphoma-2 and nitric oxide in primary breast cancer patients.
Ahmed HH; Metwally FM; Mahdy ES; Shosha WG; Ramadan SS
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):958-65. PubMed ID: 22953646
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
6. A novel panel of microRNAs provides a sensitive and specific tool for the diagnosis of breast cancer.
Luo J; Zhao Q; Zhang W; Zhang Z; Gao J; Zhang C; Li Y; Tian Y
Mol Med Rep; 2014 Aug; 10(2):785-91. PubMed ID: 24866395
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage.
Günel N; Coskun U; Sancak B; Hasdemir O; Sare M; Bayram O; Celenkoglu G; Ozkan S
Am J Clin Oncol; 2003 Aug; 26(4):416-21. PubMed ID: 12902898
[TBL] [Abstract][Full Text] [Related]
8. Effect of nitric oxide and malondialdehyde on sister-chromatid exchanges in breast cancer.
Ray GN; Shahid M; Husain SA
Br J Biomed Sci; 2001; 58(3):169-76. PubMed ID: 11575740
[TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
[TBL] [Abstract][Full Text] [Related]
10. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
Ławicki S; Będkowska GE; Wojtukiewicz M; Szmitkowski M
Adv Med Sci; 2013; 58(2):207-15. PubMed ID: 23846151
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of proteolytic activity imbalance in breast cancer diagnosis.
Swellam M; Soliman HA; Abdelmaksoud MD; Nageeb AM; El Arab LR; Boshnak H
Cancer Biomark; 2014; 14(6):409-17. PubMed ID: 25335732
[TBL] [Abstract][Full Text] [Related]
13. Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma.
Pande D; Negi R; Karki K; Khanna S; Khanna RS; Khanna HD
Transl Res; 2012 Dec; 160(6):411-8. PubMed ID: 22885175
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of immunological methods in patients with tuberculous pleural effusion from Venezuela.
Fernández de Larrea C; Duplat A; Giampietro F; de Waard JH; Luna J; Singh M; Araujo Z
Invest Clin; 2011 Mar; 52(1):23-34. PubMed ID: 21612137
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.
Okamoto M; Kawabe T; Iwasaki Y; Hara T; Hashimoto N; Imaizumi K; Hasegawa Y; Shimokata K
J Lab Clin Med; 2005 Feb; 145(2):88-93. PubMed ID: 15746651
[TBL] [Abstract][Full Text] [Related]
16. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
17. Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models.
Hwa HL; Kuo WH; Chang LY; Wang MY; Tung TH; Chang KJ; Hsieh FJ
J Eval Clin Pract; 2008 Apr; 14(2):275-80. PubMed ID: 18284517
[TBL] [Abstract][Full Text] [Related]
18. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.
Benoy IH; Salgado R; Van Dam P; Geboers K; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Clin Cancer Res; 2004 Nov; 10(21):7157-62. PubMed ID: 15534087
[TBL] [Abstract][Full Text] [Related]
19. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
20. IL-18 and interferon-gamma in HCV-related hepatocellular carcinoma: a model of interplay between immune status and cancer.
Perrella O; Cuomo O; Sbreglia C; Monaco A; Gnarini MR; Gentile B; Perrella M; Perrella A
J Biol Regul Homeost Agents; 2009; 23(4):251-8. PubMed ID: 20003764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
